Joint ECDC-EFSA assessment - Outbreak of hepatitis A virus infection in four Nordic countries
Between 1 October 2012 and 8 April 2013, 16 confirmed cases of hepatitis A virus (HAV) infections with subgenotype IB and identical RNA sequence were reported in four Nordic countries.
Communicable disease threats report 3-9 February 2013, week 6
From 3 February to 9 February 2013, ECDC monitored several on-going public health threats within and outside the European Union
Association of childhood narcolepsy and cataplexy and receipt of a pandemic influenza vaccine in Finland in 2009-10 – First papers in a peer review journalArchived
A pair of linked papers from Finland concerning the above topic, one epidemiological and the second combining both clinical and epidemiological were published on March 28th in the open access journal, PLoS One.(1,2).
Narcolepsy and Pandemrix Vaccine – an association in adults as well as childrenArchived
In September 2010 Sweden and Finland noted a number of children had developed narcolepsy seemingly in association with having received the pandemic vaccine used almost exclusively in those countries (Pandemrix)
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.
Epidemiological update: outbreak of hepatitis A virus infection in four Nordic countries
As of 6 August 2013, the Danish, Finnish, Norwegian and Swedish public health institutes reported 106 cases associated with the hepatitis A virus (HAV) infection outbreak affecting their countries since 1 October 2012. Of these, 64 were confirmed and 42 were probable.